128 related articles for article (PubMed ID: 38244229)
1. Nuclear translocation matters: Role of FABP7 in driving glioblastoma stemness and invasion: Reply to Mu et al.
Liu RZ; Choi WS; Godbout R
Neuro Oncol; 2024 Mar; 26(3):590-591. PubMed ID: 38244229
[No Abstract] [Full Text] [Related]
2. FABP7 Facilitates Uptake of Docosahexaenoic Acid in Glioblastoma Neural Stem-like Cells.
Choi WS; Xu X; Goruk S; Wang Y; Patel S; Chow M; Field CJ; Godbout R
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444824
[TBL] [Abstract][Full Text] [Related]
3. Polyunsaturated fatty acid-binding protein FABP7, an attractive metabolic target for inhibition of glioblastoma stem cells.
Sun Y; Mu G; Xue Z; Wang S; Li X; Ni S; Han M
Neuro Oncol; 2024 Mar; 26(3):587-589. PubMed ID: 38244234
[No Abstract] [Full Text] [Related]
4. Fatty acid binding protein 7 as a marker of glioma stem cells.
Morihiro Y; Yasumoto Y; Vaidyan LK; Sadahiro H; Uchida T; Inamura A; Sharifi K; Ideguchi M; Nomura S; Tokuda N; Kashiwabara S; Ishii A; Ikeda E; Owada Y; Suzuki M
Pathol Int; 2013 Nov; 63(11):546-53. PubMed ID: 24274717
[TBL] [Abstract][Full Text] [Related]
5. FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status.
Kaloshi G; Mokhtari K; Carpentier C; Taillibert S; Lejeune J; Marie Y; Delattre JY; Godbout R; Sanson M
J Neurooncol; 2007 Sep; 84(3):245-8. PubMed ID: 17415524
[TBL] [Abstract][Full Text] [Related]
6. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
7. A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells.
De Rosa A; Pellegatta S; Rossi M; Tunici P; Magnoni L; Speranza MC; Malusa F; Miragliotta V; Mori E; Finocchiaro G; Bakker A
PLoS One; 2012; 7(12):e52113. PubMed ID: 23284888
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
[TBL] [Abstract][Full Text] [Related]
9. Nuclear FABP7 regulates cell proliferation of wild-type IDH1 glioma through caveolae formation.
Kagawa Y; Umaru BA; Kanamori M; Zama R; Shil SK; Miyazaki H; Kobayashi S; Wannakul T; Yang S; Tominaga T; Owada Y
Mol Oncol; 2022 Jan; 16(1):289-306. PubMed ID: 34716958
[TBL] [Abstract][Full Text] [Related]
10. Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma.
Hoang-Minh LB; Siebzehnrubl FA; Yang C; Suzuki-Hatano S; Dajac K; Loche T; Andrews N; Schmoll Massari M; Patel J; Amin K; Vuong A; Jimenez-Pascual A; Kubilis P; Garrett TJ; Moneypenny C; Pacak CA; Huang J; Sayour EJ; Mitchell DA; Sarkisian MR; Reynolds BA; Deleyrolle LP
EMBO J; 2018 Dec; 37(23):. PubMed ID: 30322894
[TBL] [Abstract][Full Text] [Related]
11. The nuclear receptor REV-ERBα regulates Fabp7 and modulates adult hippocampal neurogenesis.
Schnell A; Chappuis S; Schmutz I; Brai E; Ripperger JA; Schaad O; Welzl H; Descombes P; Alberi L; Albrecht U
PLoS One; 2014; 9(6):e99883. PubMed ID: 24932636
[TBL] [Abstract][Full Text] [Related]
12. Brain fatty acid binding protein (Fabp7) is diurnally regulated in astrocytes and hippocampal granule cell precursors in adult rodent brain.
Gerstner JR; Bremer QZ; Vander Heyden WM; Lavaute TM; Yin JC; Landry CF
PLoS One; 2008 Feb; 3(2):e1631. PubMed ID: 18286188
[TBL] [Abstract][Full Text] [Related]
13. Oleic acid-bound FABP7 drives glioma cell proliferation through regulation of nuclear lipid droplet formation.
Umaru BA; Kagawa Y; Ohsaki Y; Pan Y; Chen CT; Chen DK; Abe T; Shil SK; Miyazaki H; Kobayashi S; Maekawa M; Yamamoto Y; Wannakul T; Yang S; Bazinet RP; Owada Y
FEBS J; 2023 Apr; 290(7):1798-1821. PubMed ID: 36325660
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies.
Shimamoto C; Ohnishi T; Maekawa M; Watanabe A; Ohba H; Arai R; Iwayama Y; Hisano Y; Toyota T; Toyoshima M; Suzuki K; Shirayama Y; Nakamura K; Mori N; Owada Y; Kobayashi T; Yoshikawa T
Hum Mol Genet; 2014 Dec; 23(24):6495-511. PubMed ID: 25027319
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid binding protein 7 mediates linoleic acid-induced cell death in triple negative breast cancer cells by modulating 13-HODE.
Kwong SC; Abd Jamil AH; Rhodes A; Taib NA; Chung I
Biochimie; 2020 Dec; 179():23-31. PubMed ID: 32931863
[TBL] [Abstract][Full Text] [Related]
16. Understanding FABP7 binding to fatty acid micelles and membranes.
Lenz S; Bodnariuc I; Renaud-Young M; Butler TM; MacCallum JL
Biophys J; 2023 Feb; 122(4):603-615. PubMed ID: 36698315
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses.
Chen J; Liu X; Zhang S; Chen J; Sun H; Zhang L; Zhang Q
Phys Chem Chem Phys; 2020 Jan; 22(4):2262-2275. PubMed ID: 31917380
[TBL] [Abstract][Full Text] [Related]
18. Neural stem cell specific fluorescent chemical probe binding to FABP7.
Yun SW; Leong C; Zhai D; Tan YL; Lim L; Bi X; Lee JJ; Kim HJ; Kang NY; Ng SH; Stanton LW; Chang YT
Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10214-7. PubMed ID: 22689954
[TBL] [Abstract][Full Text] [Related]
19. ω-3 and ω-6 Fatty Acids Modulate Conventional and Atypical Protein Kinase C Activities in a Brain Fatty Acid Binding Protein Dependent Manner in Glioblastoma Multiforme.
Elsherbiny ME; Chen H; Emara M; Godbout R
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29642372
[TBL] [Abstract][Full Text] [Related]
20. FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis.
Cordero A; Kanojia D; Miska J; Panek WK; Xiao A; Han Y; Bonamici N; Zhou W; Xiao T; Wu M; Ahmed AU; Lesniak MS
Oncogene; 2019 Sep; 38(37):6445-6460. PubMed ID: 31324889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
